EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants

Zongda Li, Panpan Chen, Aihua Qu, Maozhong Sun, Liguang Xu, Chuanlai Xu, Shudong Hu, Hua Kuang iD

Small Methods · 2025-07 · 9 (7)

DOI: 10.1002/smtd.202402059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 25.04.2025. Verfasst von Zongda Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Research Laboratory for Biointerface and Biodetection, State Key Laboratory of Food Science and Technology, School of Food Scienc…. Hauptthemen laut MEDLINE: Nanostructures, Adjuvants, Vaccine, Adjuvants, Immunologic, Vaccines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 181 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adjuvants, as a critical component of vaccines, are capable of eliciting more robust and sustained immune responses. Nanomaterials have shown unique advantages and broad application prospects in adjuvant development due to their high adjustability and distinctive physicochemical properties. This review focuses on nanoadjuvants and their immunological mechanisms. First, various types of adjuvants are introduced with an emphasis on metal and metal oxide nanoparticles, coordination polymers, liposomes, polymer nanoparticles, and other inorganic nanoparticles that can serve as vaccine adjuvants. Second, this review describes the current status of the clinical applications of nanoadjuvants. Next, the mechanisms of action for nanoadjuvants have been thoroughly elucidated, including the depot effect, NLRP3 inflammasome activation, targeting C‐type lectin receptors, activation of toll‐like receptors, and activation of the cGAS‐STING signaling pathway. Finally, the challenges and opportunities associated with the development of nanoadjuvants have also been addressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanostructuresAdjuvants, VaccineAdjuvants, ImmunologicVaccinesHumansAnimalsNanoparticlesInflammasomesLiposomes

Stichwörter der Autor:innen

adjuvantbiological applicationsfabricationmechanismnanomaterialsvaccine

Substanzen

Adjuvants, VaccineAdjuvants, ImmunologicVaccinesInflammasomesLiposomes

Autor:innen und Institutionen

  • International Joint Research Laboratory for Biointerface and Biodetection, State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, China.

ORCID-Profile: Hua Kuang

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Li, Z., Chen, P., Qu, A., Sun, M., Xu, L., Xu, C., Hu, S., & Kuang, H. (2025). Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants. Small Methods, 9(7). https://doi.org/10.1002/smtd.202402059

Vancouver

Li Z, Chen P, Qu A, Sun M, Xu L, Xu C, et al. Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants. Small Methods. 2025;9(7). doi:10.1002/smtd.202402059

BibTeX
@article{Li2025,
  author = {Li, Zongda and Chen, Panpan and Qu, Aihua and Sun, Maozhong and Xu, Liguang and Xu, Chuanlai and Hu, Shudong and Kuang, Hua},
  title = {Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants},
  journal = {Small Methods},
  year = {2025},
  volume = {9},
  number = {7},
  doi = {10.1002/smtd.202402059}
}
Kostenlos starten →